MPHS Diabetes Expert Dr. David Klonoff Elected as AIMBE Fellow
David C. Klonoff, M.D., FACP, medical director of the Diabetes Research Institute at Mills-Peninsula Health Services, has been elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). He will be inducted at the Fellow Induction and Awards Ceremony at AIMBE’s 22nd annual event in February, 2013 in Washington, D.C.
Being named a Fellow is considered one of the highest honors in the biomedical engineering discipline. Fellows represent the top two percent of the medical and biological engineering community.
AIMBE Fellows are leaders in bioengineering who are working to realize the institute’s vision to provide medical and biological engineering innovation for the benefit of humanity. The AIMBE College of Fellows consists of 1,000 individuals who are the outstanding bioengineers in academia, industry and government. These leaders in the field have distinguished themselves through their contributions in research, industrial practice and/or education.
“The mission of AIMBE is to promote public policies to foster advancement in medical and biological engineering,” Dr. Klonoff said. “At the Mills-Peninsula Diabetes Research Institute, we are applying advances in medical and bioengineering to develop new products to help people with diabetes. This award will help call attention to our hospital’s efforts to develop novel engineered devices, drug delivery systems and new medications that are safe and effective in the fight against diabetes, which is the world’s greatest epidemic.”
About Dr. David Klonoff
Dr. David Klonoff founded the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services to facilitate development of new devices and drugs for people with diabetes. He is also a Clinical Professor of Medicine at the University of California, San Francisco (UCSF). Dr. Klonoff’s productivity includes 160 publications, two patents, and 86 clinical trials as principle investigator. Dr. Klonoff chaired the scientific advisory board for developing the first FDA-approved insulin patch pump and participated in development of the first FDA-approved dedicated diabetes telemedicine system, the first FDA-approved inhaled insulin, and the first three FDA-approved incretin drugs for diabetes. He is currently the lead investigator for the first-ever randomized controlled multicenter trial of the world’s first artificial pancreas product for outpatient use. Dr. Klonoff has chaired or served on 34 government grant review panels related to diabetes technology, including panels for National Institutes of Health, the Centers for Disease Control and Prevention, NASA, National Science Foundation, U.S. Army, JDRF, and the University of Michigan.
Dr. Klonoff is a graduate of the University of California, Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His post graduate training included two years at University of California, Los Angeles Hospital and three years at UCSF hospitals. He has been practicing endocrinology in Burlingame and has been a member of the medical staff of Mills-Peninsula Health Services since 1981.
Dr. Klonoff has served as a civilian medical officer for the U.S. Army’s Telemedicine & Advanced Technology Research Center (TATRC) for biosensors and physiologic monitoring, and chaired the CDC’s initiative, “Sticking with Safety,” for safe blood glucose monitoring to avoid transmitting blood-borne viruses. He also led technical and clinical guideline panels about continuous glucose monitoring for CLSI & Endocrine Society. Dr. Klonoff received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. He is the only diabetes expert to receive that award. Dr. Klonoff was cited in 2011 as being in the top one percent of endocrinologists nationally by US News & World Report in collaboration with Castle Connolly Medical Ltd. Dr. Klonoff received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialties Centre and Madras Diabetes Research Foundation of Chennai, India, which is the world’s largest diabetes clinic.
If you liked this article, you may also like:
Mills Receives Stroke Care Award Soul Stroll for Health May 21 Mills-Peninsula Announces New Treatment for Peripheral Artery Disease